ProstACT Global is trialling a promising new treatment option for prostate cancer, which is the most commonly diagnosed cancer and the second leading cause of cancer-related death for U.S. men. This ...

Mantra Health has expanded its suite of mental health and wellness services to better support the campus community. With new solutions designed to address urgent mental health needs, streamline ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) announces that the Biogenix Molecular Research Center ...

A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway in the progression of diabetic nephropathy (DN) and explores its potential ...

DelveInsight's Advanced Therapy Medicinal Products Market Insights report provides the current and forecast market analysis, ...

Choosing to start psychotherapy takes courage and persistence. Identifying resistance to the therapuetic process goes a long ...

FDA feedback confirms Adial’s proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging requirement for the ...

One particular challenge in the treatment of cancer is therapy resistance. An international research team has now discovered a mechanism that opens up new treatment strategies for tumors in which ...

The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The rising prevalence of genetic disorders and cancer, along ...

Proton arc therapy offers a superior dose distribution compared with existing state-of-the-art proton delivery techniques ...

Dania Daye, MD, PhD Associate Professor of Radiology, Harvard Medical School IR Division Quality Director Co-Director of IR ...